Budesonide
- Strength
- .25 mg/2mL
- Form
- Suspension
- Class
- Corticosteroid
Sun Pharmaceutical Industries, Inc.
budesonide, glycopyrrolate, and formoterol fumarate
Listed by AstraZeneca Pharmaceuticals LP
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Aerosol, Metered |
|---|---|
| Route | Respiratory (inhalation) |
| Drug class | Anticholinergic; Cholinergic Muscarinic Antagonist; Corticosteroid; beta2-Adrenergic Agonist |
| Approval route | NDA — original brand approval |
| NDC code | 0310-4616 |
| FDA application | NDA212122 |
| RxNorm concept | 2387326 |
| Package sizes listed | 3 |
| Marketed since | July 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sun Pharmaceutical Industries, Inc.
Cardinal Health 107, LLC
Aurobindo Pharma Limited
Zydus Pharmaceuticals USA Inc.
CVS Pharmacy
Northstar Rx LLC.
Teva Pharmaceuticals USA, Inc.
A-S Medication Solutions
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.